로고

INTRODUCTION

MEMBERS

RESEARCH

BOARD

RESEARCH

Pharmaceutical Economics,
Big Data Analysis & Policy Lab

Conference presentations

Total 168건 9 페이지

2019
48

"Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A nationwide population-based study in Korea" Han S, Kim YH, Lee MY, Bang OY, Jang SW, Han S, Lee SH, Lee JM, Park YJ, Choi HY, Kang SS, On YK, and Suh HS , The 12th Asia Pacific Heart Rhythm Society Scientific Session Bangkok, Thailand. October 2019.
47

"Multiple aTherosclerotic cardiovascular diseases and familial hypercholesterolemia in Korea: A National Health Insurance Service-Health Screening Database Analysis" Kim H, Kim S, Han S, Yi H, Han H, and Suh HS , The 2019 Fall International Convention of The Pharmaceutical Society of Korea Seoul, Korea. October 2019.
46

"Patient characteristics associated with hospitalization through emergency department visit with asthma exacerbation: Association rule mining approach" Han S and Suh HS , The 24th International Society for Pharmacoeconomics and Outcomes Research Annual Meeting New Orleans LA, USA. May 2019.
45

"Severe and uncontrolled asthma in South Korea: Proportion of exacerbation leading to hospitalization or intensive care unit admission" Han S and Suh HS , The 24th International Society for Pharmacoeconomics and Outcomes Research Annual Meeting New Orleans LA, USA. May 2019.
44

"Exploring treatment patterns and prognosis of patients with an incident drug-induced parkinsonism" Kim S, Kim E, and Suh HS , The 24th International Society for Pharmacoeconomics and Outcomes Research Annual Meeting New Orleans, LA, USA. May 2019.
43

"Cultural adaptation and validation of The Korean version of iMTA productivity cost questionnaire (IPCQ)" Kim H, Kim S, Han S, Lee JM, Park KS, Yoo JE, and Suh HS , The 24th International Society for Pharmacoeconomics and Outcomes Research Annual Meeting New Orleans, USA. May 2019.
42

"Cardiovascular event rates according to LDL-C goal achievement in dyslipidemia patients in South Korea" Kim S, Han S, An J, Yi H, Han H, and Suh HS , The 2019 Spring International Convention of The Pharmaceutical Society of Korea Seoul, Korea. April 2019.
41

"Validation of The Patient Satisfaction Questionnaire (PSQ) for pharmaceutical care in hospital settings" Kim H, Kim KI, Kim S, Han N, Bae Su, Lee E, Oh JM, Lee E, and Suh HS , The 2019 Spring International Convention of The Pharmaceutical Society of Korea Seoul, Korea. April 2019.
2018
40

"Cost-effectiveness of cabozantinib for patients with advanced renal cell carcinoma after failure of prior Therapy in South Korea" Kim S, Han S, Kim H, and Suh HS , The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress Barcelona, Spain. November 2018.
39

"Cost-effectiveness analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β2-agonists in South Korea" Han S, Kim S, Kim H, and Suh HS , The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress Barcelona, Spain. November 2018.
38

"The impact of Ministry of Food and Drug Safety (MFDS) safety notice on The use of metoclopramide in Korea: a population-based study with an interrupted time series analysis" Kim H, Kim S, Han S, and Suh HS , The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress Barcelona, Spain. November 2018.
37

"Treatment patterns and clinical characteristics among non-valvular atrial fibrillation patients prescribed oral anticoagulants: a nationwide population-based study in Korea" Lee M , Han S, Bang O, On Y, Jang S, Han S, Won M, Park Y, Shin J, Kang S, Suh HS, and Kim Y , The 2018 American Heart Association Scientific Sessions Chicago, USA. November 2018
36

"Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation: A Nationwide Population-Based Study in Korea" Han S, Bang O, On Y, Lee M, Jang S, Han S, Won M, Park Y, Shin J, Kang S, Suh HS, and Kim Y , The 11th Asia Pacific Heart Rhythm Society Scientific Session Taipei, Taiwan. October 2018.
35

"Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban versus Warfarin in Non-Valvular Atrial Fibrillation: A Nationwide Population-Based Study in Korea" Bang O, On Y, Lee M, Jang S, Han S, Han S, Won M, Park Y, Shin J, Kang S, Suh HS, and Kim Y , The 11th Asia Pacific Heart Rhythm Society Scientific Session Taipei, Taiwan. October 2018.
34

"Cost-effectiveness of Dangguijagyag-san for treating primary dysmenorrhea: Study protocol of a multicenter randomized controlled trial" Kim S, Park KS, Lee JM, and Suh HS , The 2018 Fall International Convention of The Pharmaceutical Society of Korea Seoul, Korea. October 2018.

검색